Discapacidad
Durante muchos años, se ha consumido demasiado tiempo y esfuerzos intentando averiguar cómo podían haber causado los padres el es autismo a sus hijos. Afortunadamente, la investigación ha documentado que el trastorno autista (T TA) tiene una etiología biológica y que las causas se encuentran en el cerebro de las personas que lo padecen y […]
…Este curso de verano de la UNED dirigido por Mª Elena Campo Adrián se impartirá del 26 al 30 de julio de 2004, en Ávila. La psicobiotecnomedicina está considerada como un campo interdisciplinar. Incluye la medicina, la psicología, la ingeniería, la biología, la genética y campos afines. Se dedica al estudio de las aplicaciones tecnológicas […]
…Histamine is a biogenic amine performing pleiotropic effects in humans, involving tasks within the immune and neuroendocrine systems, neurotransmission, gastric secretion, cell life and death, and development. It is the product of the histidine decarboxylase activity, and its effects are mainly mediated through four different G-protein coupled receptors. Thus, histamine-related effects are the results of […]
…The recent advances on genomics and proteomics research bring up a significant grow on the information that is publicly available. However, navigating through genetic and bioinformatics databases can be a too complex and unproductive task for a primary care physician. In this paper we present diseasecard, a web portal for rare disease that provides transparently […]
…Rare diseases (RD) are becoming increasingly important as possible targets of new forms of treatment, as a valuable source of a novel insight in fundamental lows of biology, and in the specific mechanisms of many diseases. Molecular methods have created a better diagnosis and oftentimes treatment. RDs pose significant problem for the patients, since their […]
…Background:Over 95% of rare diseases lack treatments despite many successful treatment studies in animal models. To improve access to treatments, the Accelerated Approval (AA) regulations were implemented allowing the use of surrogate endpoints to achieve drug approval and accelerate development of life-saving therapies. Many rare diseases have not utilized AA due to the difficulty in […]
…Biobanking is of high importance for research in rare diseases. There are >6,000 rare diseases with at least 30 million people affected in the European Union (EU). The European Commission (EC) has prioritized rare diseases in recent health and research programs. The rarity and diversity of rare diseases and their associated biomaterials harbor specific challenges […]
…Rare diseases (RD) are characterized by low prevalence and affect not more than five individuals per 10,000 in the European population; they are a large and heterogeneous group of disorders including more than 7,000 conditions and often involve all organs and tissues, with several clinical subtypes within the same disease. Very often information concerning either […]
…
